⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9701132 | 0.61 | — | — | |
| SCHEMBL11752872 | 0.58 | — | — | |
| SCHEMBL10463581 | 0.58 | — | — | |
| SCHEMBL4691188 | 0.58 | — | — | |
| SCHEMBL21233317 | 0.56 | — | — | |
| SCHEMBL22430320 | 0.56 | — | — | |
| Water SCHEMBL9615097 | 0.55 | — | — | |
| SCHEMBL5453261 | 0.52 | — | — | |
| SCHEMBL22340611 | 0.51 | — | — | |
| SCHEMBL18944232 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9491941-B2 | (Hetero) arylacrylamides for the control of ectoparasites | NOVARTIS TIERGESUNDHEIT AG (CH) | 2016-11-15 | — | — | US | disclosed |
| US-20150320044-A1 | (HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES | ELANCO TIERGESUNDHEIT AG (CH) | 2015-11-12 | — | — | US | disclosed |